CNC1C(O)[C@@H]2OC(O[C@@H]3C(O)C(O)C(N)C[C@H]3N)C(N)C[C@H]2O[C@H]1O[C@@H]1OC(CO)C(N)C(O)C1O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?